Differences
This shows you the differences between two versions of the page.
Next revision | Previous revision | ||
billirubin [2025/01/27 10:46] – created admin | billirubin [2025/01/27 11:12] (current) – admin | ||
---|---|---|---|
Line 1: | Line 1: | ||
+ | |[[clinical_biochemistry_section|Home]]|[[clinical_biochemistry|]]|[[examination_procedures|]]| | ||
+ | |||
+ | |||
+ | Total Bilirubin Examination Procedure | ||
**1.Purpose of examination: | **1.Purpose of examination: | ||
* Bilirubin Total estimation from serum or plasma by Diazonium Salt Method. | * Bilirubin Total estimation from serum or plasma by Diazonium Salt Method. | ||
Line 11: | Line 15: | ||
* Type of Sample: Serum, | * Type of Sample: Serum, | ||
* Type of container and additives: Plain without any additives | * Type of container and additives: Plain without any additives | ||
- | * Patient Preparation: | + | * Patient Preparation: |
* Stability: At Room temperature 18°–28°C (64°–82°F) stability ≤ 24 hours | * Stability: At Room temperature 18°–28°C (64°–82°F) stability ≤ 24 hours | ||
* Handling and transport: As per Primary Sample collection manual | * Handling and transport: As per Primary Sample collection manual | ||
Line 17: | Line 21: | ||
**4.Required Equipment: | **4.Required Equipment: | ||
- | ●Centrifuge, Auto-Pipette, | + | * Centrifuge, Auto-Pipette, |
**5.Required reagents:** | **5.Required reagents:** | ||
Line 23: | Line 27: | ||
Hydrochloric acid 9.33 g/L | Hydrochloric acid 9.33 g/L | ||
* R2. 2, 4-dichloroaniline 0.81 g/L | * R2. 2, 4-dichloroaniline 0.81 g/L | ||
- | | + | Hydrochloric acid 5.563 g/L |
- | Sodium nitrite | + | Sodium nitrite |
- | | + | Surfactant |
**6.Reagent Handling** | **6.Reagent Handling** | ||
* Remove any air bubbles present in the reagents with a new applicator stick, or allow the reagents to settle at the appropriate storage temperature to allow the bubbles to dissipate. To minimize volume depletion, do not use a transfer pipette to remove bubbles | * Remove any air bubbles present in the reagents with a new applicator stick, or allow the reagents to settle at the appropriate storage temperature to allow the bubbles to dissipate. To minimize volume depletion, do not use a transfer pipette to remove bubbles | ||
Line 105: | Line 110: | ||
^1-2 d^6.0-10.0^mg/ | ^1-2 d^6.0-10.0^mg/ | ||
^3-5 d^4.0-8.0^mg/ | ^3-5 d^4.0-8.0^mg/ | ||
- | ^1 week -18 years^0-2.06mg/dL^ | + | ^1 week -18 years^0-2.06^mg/dL^ |
^Adult^0.2-1.5^mg/ | ^Adult^0.2-1.5^mg/ | ||
Line 128: | Line 133: | ||
* Software backup | * Software backup | ||
* Machine raw data | * Machine raw data | ||
+ | |||
**18.Storage & Disposal of waste:** Follow storage & discard procedure | **18.Storage & Disposal of waste:** Follow storage & discard procedure | ||
+ | |||
**19.Environmental & Safety control:** | **19.Environmental & Safety control:** | ||
**Reagent R1** contains hydrochloric acid and sodium borohydride. Reagent R2 contains hydrochloric acid. | **Reagent R1** contains hydrochloric acid and sodium borohydride. Reagent R2 contains hydrochloric acid. | ||
that Causes severe skin burns and eye damage. | that Causes severe skin burns and eye damage. | ||
- | May be corrosive to metals | + | May be corrosive to metal |
**20.Precautions: | **20.Precautions: | ||
* Keep only in original container. | * Keep only in original container. | ||
Line 146: | Line 154: | ||
- ARCHITECT | - ARCHITECT | ||
- NABL 112 effective from 01/06/2019 | - NABL 112 effective from 01/06/2019 | ||
+ | |||
+ | |**Printed copy of this document is considered uncontrolled.** It should be compared with controlled electronic copy before use| | ||
+ | |||
+ | ^ Name of Laboratory : Laboratory Services Sir T. Hospital (LSSTH), | ||
+ | ^Document No.1^**Document Name**: Total Bilirubin Examination Procedure^**Unique ID**:LSSTH /BIOCHEM/ SOP-5^^ | ||
+ | ^Issue No. : 01^Issue Date : | ||
+ | ^Amend No.^ Amend Date ^Prepared by: Section Incharge^Approved & Issued by: HOD, | ||